Literature DB >> 18066612

Is anticoagulation unnecessary in Behcet's disease with deep venous thrombosis?

Cengiz Korkmaz.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 18066612     DOI： 10.1007/s10067-007-0805-9

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN： 0770-3198            Impact factor:   2.980


× No keyword cloud information.
  7 in total

1.  Budd-Chiari syndrome in the course of Behcet's disease: clinical and laboratory analysis of four cases.

Authors:  Cengiz Korkmaz; Timuçin Kasifoglu; Mahmut Kebapçi
Journal:  Joint Bone Spine       Date:  2007-02-22       Impact factor: 4.929

2.  Arterial thrombosis leading to intestinal infarction in a patient with Behçet's disease associated with protein C deficiency.

Authors:  Y Bayraktar; A R Soylu; F Balkanci; G Gedikoğlu; M Cakmakçi; I Sayek
Journal:  Am J Gastroenterol       Date:  1998-12       Impact factor: 10.864

Review 3.  Vasculitis in Behçet's disease.

Authors:  J D O'Duffy
Journal:  Rheum Dis Clin North Am       Date:  1990-05       Impact factor: 2.670

4.  Inflammatory response in the acute phase of deep vein thrombosis.

Authors:  Edith M Roumen-Klappe; Martin den Heijer; Stan H M van Uum; Johanna van der Ven-Jongekrijg; Fedde van der Graaf; Hub Wollersheim
Journal:  J Vasc Surg       Date:  2002-04       Impact factor: 4.268

5.  Coagulation factor V gene mutation increases the risk of venous thrombosis in behçet's disease.

Authors:  A Gül; U Ozbek; C Oztürk; M Inanç; M Koniçe; T Ozçelik
Journal:  Br J Rheumatol       Date:  1996-11

6.  Behçet syndrome associated with protein S deficiency.

Authors:  O Chafa; A M Fischer; F Meriane; T Chellali; C Sternberg; F Otmani; M Benabadji
Journal:  Thromb Haemost       Date:  1992-01-23       Impact factor: 5.249

7.  Treatment of venous thrombosis associated with Behcet's disease: immunosuppressive therapy alone versus immunosuppressive therapy plus anticoagulation.

Authors:  Joong Kyong Ahn; You Sun Lee; Chan Hong Jeon; Eun-Mi Koh; Hoon-Suk Cha
Journal:  Clin Rheumatol       Date:  2007-07-17       Impact factor: 2.980
  7 in total
  3 in total

Review 1.  Behçet's disease: recent advances in early diagnosis and effective treatment.

Authors:  Kenneth T Calamia; Phaedon G Kaklamanis
Journal:  Curr Rheumatol Rep       Date:  2008-10       Impact factor: 4.592

2.  Combined thrombophilic factors increase the risk of recurrent thrombotic events in Behcet's disease.

Authors:  N Şule Yaşar; Füsun Salgür; Döndü Ü Cansu; Timuçin Kaşifoğlu; Cengiz Korkmaz
Journal:  Clin Rheumatol       Date:  2010-04-11       Impact factor: 2.980

3.  Consider Behcet's disease in young patients with deep vein thrombosis.

Authors:  Adil Can Güngen; Hikmet Çoban; Yusuf Aydemir; Hasan Düzenli
Journal:  Respir Med Case Rep       Date:  2016-04-14
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.